Rivian Automotive, Inc. / DE (RIVN) Spending and interest coverage
- R&D / revenue · 12 months: Value 30.61%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 13.55%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 30.61% | Research and development expense / revenue. Period ending 2026-06-30. $1.80B ÷ $5.88B × 100 ≈ 30.61% |
| Stock-based compensation / revenue · 12 months | 13.55% | Share-based compensation / revenue. Period ending 2026-06-30. $797.00M ÷ $5.88B × 100 ≈ 13.55% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 1.80B USD | Research and Development Expense |
| Revenue | 5.88B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 797.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -3.53B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.80B | $5.88B | $797.00M | $-3.53B | (m) | 30.61% | 13.55% | (m) | (m) |
| 2026-03-31 | $1.75B | $5.53B | $760.00M | $-3.81B | (m) | 31.57% | 13.75% | (m) | (m) |
| 2025-12-31 | $1.67B | $5.39B | $741.00M | $-3.58B | (m) | 30.96% | 13.76% | (m) | (m) |
| 2025-09-30 | $1.62B | $5.83B | $705.00M | $-3.41B | (m) | 27.73% | 12.08% | (m) | (m) |
| 2025-06-30 | $1.51B | $5.15B | $642.00M | $-3.60B | (m) | 29.41% | 12.46% | (m) | (m) |
| 2025-03-31 | $1.53B | $5.01B | $647.00M | $-3.86B | (m) | 30.62% | 12.92% | (m) | (m) |
| 2024-12-31 | $1.61B | $4.97B | $692.00M | $-4.69B | (m) | 32.45% | 13.92% | (m) | (m) |
| 2024-09-30 | $1.76B | $4.55B | $753.00M | $-5.61B | (m) | 38.78% | 16.55% | (m) | (m) |
| 2024-06-30 | $1.94B | $5.01B | $884.00M | $-5.88B | (m) | 38.77% | 17.63% | (m) | (m) |
| 2024-03-31 | $1.96B | $4.98B | $871.00M | $-5.79B | $257.00M | 39.38% | 17.50% | -22.53× | Reported |
| 2023-12-31 | $2.00B | $4.43B | $821.00M | $-5.74B | $220.00M | 44.99% | 18.52% | -26.09× | Reported |
| 2023-09-30 | $1.87B | $3.78B | $741.00M | $-5.95B | $180.00M | 49.47% | 19.59% | -33.07× | Reported |
| 2023-06-30 | $1.79B | $2.98B | $792.00M | $-6.29B | $149.00M | 60.18% | 26.57% | -42.19× | Reported |
| 2023-03-31 | $1.89B | $2.22B | $853.00M | $-6.71B | $119.00M | 85.12% | 38.35% | -56.39× | Reported |
| 2022-12-31 | $1.94B | $1.66B | $987.00M | $-6.86B | $103.00M | 117.25% | 59.53% | -66.56× | Reported |
| 2022-09-30 | $2.27B | $1.05B | $1.42B | $-7.51B | $92.00M | 216.21% | 135.56% | -81.68× | Reported |
| 2022-06-30 | $2.26B | $514.00M | $1.13B | $-6.52B | $69.00M | 439.11% | 219.65% | -94.45× | Reported |
| 2022-03-31 | $2.11B | $150.00M | $887.00M | $-5.39B | $46.00M | 1405.33% | 591.33% | -117.15× | Reported |
| 2021-12-31 | $1.85B | $55.00M | $570.00M | $-4.22B | $29.00M | 3363.64% | 1036.36% | -145.52× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $766.00M | $0.00 | $0.00 | $-1.02B | $8.00M | (m) | (m) | -127.63× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $301.00M | $0.00 | $0.00 | $-409.00M | $34.00M | (m) | (m) | -12.03× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.